The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective

por Griffiths, A, Paracha, N, Davies, A, Branscombe, N, Cowie, M R, Sculpher, M
Publicado 2014

EE572 Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgavimab) for Pre-exposure Prophylaxis Against COVID-19 in the Immunocompromised Population

por Sutton, K, Miller, P, Branscombe, N, Mittal, M, Browne, C, Arnetorp, S, Henry, T, Breslin, K, Bungey, G, Quint, J, Montgomery, H
Publicado 2022